110 related articles for article (PubMed ID: 35338663)
1. Ofloxacin-loaded HMPB NPs for Klebsiella pneumoniae eradication in the surgical wound with the combination of PTT.
Liu T; Zhong G; Tang D; Liu X; Fan J; Zhong X; Yang Y; Tong C; Liu B; Yang X
Biotechnol Bioeng; 2022 Jul; 119(7):1949-1964. PubMed ID: 35338663
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial polymers as therapeutics for treatment of multidrug-resistant Klebsiella pneumoniae lung infection.
Lou W; Venkataraman S; Zhong G; Ding B; Tan JPK; Xu L; Fan W; Yang YY
Acta Biomater; 2018 Sep; 78():78-88. PubMed ID: 30031912
[TBL] [Abstract][Full Text] [Related]
3. Carbapenemases producing Klebsiella pneumoniae from the pus of hospitalized patients: In-vitro antibiotic properties of Streptomyces against multidrug resistant infectious bacteria.
Balasubramanian B; Benit N; Agastian P; Almaary KS; Dawoud TM; Elbadawi YB; Mubarak A; Alfadul MS; Aljowaie RM
J Infect Public Health; 2021 Jul; 14(7):892-897. PubMed ID: 34119841
[TBL] [Abstract][Full Text] [Related]
4. Short and long courses of ofloxacin therapy of Klebsiella pneumoniae sepsis following irradiation.
Brook I; Ledney GD
Radiat Res; 1992 Apr; 130(1):61-4. PubMed ID: 1561319
[TBL] [Abstract][Full Text] [Related]
5. Construction Of High Loading Natural Active Substances Nanoplatform and Application in Synergistic Tumor Therapy.
Liu H; Jiapaer Z; Meng F; Wu W; Hou C; Duan M; Qin Y; Shao S; Zhang M
Int J Nanomedicine; 2022; 17():2647-2659. PubMed ID: 35730051
[TBL] [Abstract][Full Text] [Related]
6. Polymyxin B and fosfomycin thwart KPC-producing Klebsiella pneumoniae in the hollow-fibre infection model.
Bulman ZP; Zhao M; Satlin MJ; Chen L; Kreiswirth BN; Walsh TJ; Nation RL; Li J; Tsuji BT
Int J Antimicrob Agents; 2018 Jul; 52(1):114-118. PubMed ID: 29486233
[TBL] [Abstract][Full Text] [Related]
7. Degradable antimicrobial polycarbonates with unexpected activity and selectivity for treating multidrug-resistant Klebsiella pneumoniae lung infection in mice.
Yang C; Lou W; Zhong G; Lee A; Leong J; Chin W; Ding B; Bao C; Tan JPK; Pu Q; Gao S; Xu L; Hsu LY; Wu M; Hedrick JL; Fan W; Yang YY
Acta Biomater; 2019 Aug; 94():268-280. PubMed ID: 31129359
[TBL] [Abstract][Full Text] [Related]
8. Quinolone therapy of Klebsiella pneumoniae sepsis following irradiation: comparison of pefloxacin, ciprofloxacin, and ofloxacin.
Brook I; Elliott TB; Ledney GD
Radiat Res; 1990 May; 122(2):215-7. PubMed ID: 2186431
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of two multidrug-resistant Klebsiella species in an Indian teaching hospital and adjoining community.
Rath S; Padhy RN
J Infect Public Health; 2014; 7(6):496-507. PubMed ID: 24996691
[TBL] [Abstract][Full Text] [Related]
10. Antibacterial and antibiofilm efficacy of Ag NPs, Ni NPs and Al
Edhari BA; Mashreghi M; Makhdoumi A; Darroudi M
J Trace Elem Med Biol; 2021 Dec; 68():126840. PubMed ID: 34425454
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Gallium Citrate Formulations against a Multidrug-Resistant Strain of Klebsiella pneumoniae in a Murine Wound Model of Infection.
Thompson MG; Truong-Le V; Alamneh YA; Black CC; Anderl J; Honnold CL; Pavlicek RL; Abu-Taleb R; Wise MC; Hall ER; Wagar EJ; Patzer E; Zurawski DV
Antimicrob Agents Chemother; 2015 Oct; 59(10):6484-93. PubMed ID: 26239978
[TBL] [Abstract][Full Text] [Related]
12. [Klebsiella pneumoniae Infections in the Intensive Care Unit: Risk Factors Related to Carbapenem Resistance and Patient Mortality].
Büyüktuna SA; Hasbek M; Çelik C; Ünlüsavuran M; Avcı O; Baltacı S; Fırtına Topcu K; Elaldı N
Mikrobiyol Bul; 2020 Jul; 54(3):378-391. PubMed ID: 32755515
[TBL] [Abstract][Full Text] [Related]
13. [Effect of ofloxacin, pefloxacin, and tobramycin on the hydrophobicity of Klebsiella pneumoniae].
Hostacká A
Epidemiol Mikrobiol Imunol; 1999 Feb; 48(1):28-30. PubMed ID: 11038674
[TBL] [Abstract][Full Text] [Related]
14. Investigation into antibacterial and wound healing properties of platelets lysate against Acinetobacter baumannii and Klebsiella pneumoniae burn wound infections.
Shariati A; Moradabadi A; Ghaznavi-Rad E; Dadmanesh M; Komijani M; Nojoomi F
Ann Clin Microbiol Antimicrob; 2021 May; 20(1):40. PubMed ID: 34044843
[TBL] [Abstract][Full Text] [Related]
15. Rapidly fatal bacteremic pneumonia caused by Klebsiella pneumoniae with K1 hypermucoviscosity phenotype in a previously healthy young man receiving levofloxacin treatment.
Chuang TY; Lin CJ; Chi CL; Liu AY; Lee SW; Lin TL; Wang JT; Hsueh PR
J Microbiol Immunol Infect; 2009 Oct; 42(5):439-41. PubMed ID: 20182675
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of antimicrobial treatment for inpatients with carbapenem-resistant Klebsiella pneumoniae infection: a systematic review of economic evidence.
Dos Santos WM; Aromataris E; Secoli SR; Matuoka JY
JBI Database System Rev Implement Rep; 2019 Dec; 17(12):2417-2451. PubMed ID: 31821188
[TBL] [Abstract][Full Text] [Related]
17. Analysis of antibiotic resistance and virulence patterns in Klebsiella pneumoniae isolated from human urinary tract infections in India.
Bobbadi S; Chinnam BK; Reddy PN; Kandhan S
Lett Appl Microbiol; 2021 Nov; 73(5):590-598. PubMed ID: 34331358
[TBL] [Abstract][Full Text] [Related]
18. The Characteristic of Virulence, Biofilm and Antibiotic Resistance of
Wang G; Zhao G; Chao X; Xie L; Wang H
Int J Environ Res Public Health; 2020 Aug; 17(17):. PubMed ID: 32872324
[No Abstract] [Full Text] [Related]
19. Repurposing the anti-viral drug zidovudine (AZT) in combination with meropenem as an effective treatment for infections with multi-drug resistant, carbapenemase-producing strains of Klebsiella pneumoniae.
DeSarno AE; Parcell BJ; Coote PJ
Pathog Dis; 2020 Dec; 78(9):. PubMed ID: 33053176
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo bactericidal activity of ceftazidime-avibactam against Carbapenemase-producing
Zhang W; Guo Y; Li J; Zhang Y; Yang Y; Dong D; Zhu D; He P; Hu F
Antimicrob Resist Infect Control; 2018; 7():142. PubMed ID: 30479755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
